Schedule 13G

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549



SCHEDULE 13G



Under the Securities and Exchange Act of 1934





Therapeutic Solutions International, Inc.

(Name of Issuer)

 

Common

(Title of Class of Securities)

 

883378 101

(CUSIP Number)

 

January 22, 2013

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this is filed:

  X .  Rule 13d-1(b)

      .  Rule 13d-1(c)

      .  Rule 13d-1(d)


*The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.


The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).




Page 1 of 4 pages




CUSIP NO. 883378101

 

Page    2     of    4    Pages

 

 

 

1

NAMES OF REPORTING PERSONS

I.R.S. IDENTIFICATION NO. OF ABOVE PERSONS (entities only)


Tad Mailander

 

 

2

CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP


(a)        .

(b)        .

 

 

3

SEC USE ONLY


 

 

4

CITIZENSHIP OR PLACE OF ORGANIZATION


United States




NUMBER OF


5


SOLE VOTING POWER


7,526,200

SHARES

BENEFICIALLY

OWNED BY

EACH

REPORTING


6


SHARED VOTING POWER


0

PERSON

 

 

WITH

7

SOLE DISPOSITIVE POWER


7,526,200

 

 

 

 

8

SHARED DISPOSITIVE POWER


0

9

AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON


7,526,200

 

 

 

10

CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES        .  


           


11


PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9


9%

 

 

12

TYPE OF REPORTING PERSON


IN




2





Item 1(a)


The name of the issuer is Therapeutic Solutions International, Inc.


Item 1(b)


The address of the Issuer's principal executive offices is: 4093 Oceanside Boulevard, Suite B

Oceanside, California 92056


Tel. Number:  760-295-7208


Item 2(a)


The name of reporting person is:  Tad Mailander


Item 2(b)


The residence address of the Reporting Person is: 835 5th Avenue, San Diego, CA 92101


Item 2(c)


The citizenship of the reporting Person is:  United States


Item 2(d)


The title of the class of securities is:  Common


Item 2(e)


The CUSIP Number of the securities is: 883378 101

 

Item 3


This statement is not filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c).


Item 4


Ownership:  


The Reporting Person’s is the beneficial owner of 7,526,200 representing 9% of the class of securities.


The Reporting Person has:


(i)

sole power to vote or to direct the vote of:  7,526,200 shares

(ii)

shared power to vote or to direct the vote of: 0 shares

(iii)

sole power to dispose or to direct the disposition of: 7,526,200 shares

(iv)

shared power to dispose or to direct the disposition of:  0 shares


Item 5  


Ownership of Five Percent or Less of Class:  Not applicable


Item 6


Ownership of More than Five Percent on Behalf of another Person: Not applicable



3





Item 7


Identification and Classification of the Subsidiary which Acquired the Security Being Reported on By the Parent Holding Company:  Not applicable


Item 8


Identification and Classification of Members of the Group:  Not applicable


Item 9


Notice of Dissolution of Group:  Not applicable


Item 10


Certification:  


By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.



SIGNATURE


After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.



April 30, 2013

Date




/s/ Tad Mailander                                  

Signature




Tad Mailander                                          

Name



4